Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.

Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC.

Kidney Int. 2019 Feb;95(2):429-438. doi: 10.1016/j.kint.2018.10.021.

PMID:
30665573
2.

Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathy
.

Sathick IJ, Zand L, Nasr SH, Leung N.

Clin Nephrol. 2019 Feb;91(2):79-86. doi: 10.5414/CN109442.

PMID:
30474593
3.

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.

Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1037-1046. doi: 10.2215/CJN.13041117. Epub 2018 May 30.

PMID:
29848505
4.

Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults.

Lepori N, Zand L, Sethi S, Fernandez-Juarez G, Fervenza FC.

Clin Kidney J. 2018 Apr;11(2):179-190. doi: 10.1093/ckj/sfx143. Epub 2018 Jan 9.

5.

The Incidence of Primary vs Secondary Focal Segmental Glomerulosclerosis: A Clinicopathologic Study.

Hommos MS, De Vriese AS, Alexander MP, Sethi S, Vaughan L, Zand L, Bharucha K, Lepori N, Rule AD, Fervenza FC.

Mayo Clin Proc. 2017 Dec;92(12):1772-1781. doi: 10.1016/j.mayocp.2017.09.011. Epub 2017 Oct 27.

6.

The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.

Zand L, Kumar R.

Endocrinol Metab Clin North Am. 2017 Dec;46(4):983-1007. doi: 10.1016/j.ecl.2017.07.008. Epub 2017 Sep 29. Review.

7.

Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia.

Gilani SI, Anderson UD, Jayachandran M, Weissgerber TL, Zand L, White WM, Milic N, Suarez MLG, Vallapureddy RR, Nääv Å, Erlandsson L, Lieske JC, Grande JP, Nath KA, Hansson SR, Garovic VD.

J Am Soc Nephrol. 2017 Nov;28(11):3363-3372. doi: 10.1681/ASN.2016111202. Epub 2017 Jul 20.

8.

What are we missing in the clinical trials of focal segmental glomerulosclerosis?

Zand L, Glassock RJ, De Vriese AS, Sethi S, Fervenza FC.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i14-i21. doi: 10.1093/ndt/gfw324. Review.

PMID:
28391338
9.

Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis.

Sethi S, Zand L, De Vriese AS, Specks U, Vrana JA, Kanwar S, Kurtin P, Theis JD, Angioi A, Cornell L, Fervenza FC.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i139-i145. doi: 10.1093/ndt/gfw299.

PMID:
28391334
10.

Outcomes of patients with renal monoclonal immunoglobulin deposition disease.

Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N.

Am J Hematol. 2016 Nov;91(11):1123-1128. doi: 10.1002/ajh.24528. Epub 2016 Aug 29.

11.

Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis.

Kittanamongkolchai W, Cheungpasitporn W, Zand L.

Clin Kidney J. 2016 Jun;9(3):387-96. doi: 10.1093/ckj/sfw045. Epub 2016 May 26.

12.

Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients.

Kwon SH, Woollard JR, Saad A, Garovic VD, Zand L, Jordan KL, Textor SC, Lerman LO.

Nephrol Dial Transplant. 2017 May 1;32(5):800-807. doi: 10.1093/ndt/gfw077.

13.

Serum Parathyroid Hormone Concentrations and Clinical Outcomes in ESRD: A Call for Targeted Clinical Trials.

Zand L, Kumar R.

Semin Dial. 2016 May;29(3):184-8. doi: 10.1111/sdi.12457. Epub 2015 Dec 17.

PMID:
26676210
14.

Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

Zand L, Torres VE, Larson TS, King BF, Sethi S, Bergstralh EJ, Angioi A, Fervenza FC.

Nephrol Dial Transplant. 2016 Aug;31(8):1290-5. doi: 10.1093/ndt/gfv394. Epub 2015 Nov 27.

15.

Lactate clearance and metabolic aspects of continuous high-volume hemofiltration.

Cheungpasitporn W, Zand L, Dillon JJ, Qian Q, Leung N.

Clin Kidney J. 2015 Aug;8(4):374-7. doi: 10.1093/ckj/sfv045. Epub 2015 Jun 17.

16.

The role of type I hypersensitivity reaction and IgE-mediated mast cell activation in acute interstitial nephritis.

Zand L, Monaghan M, Griffin BR, Wagner SJ, Criaci IM, Kamal A, Raissian Y, Grande JP, Lim KG, Garovic VD.

Clin Nephrol. 2015 Sep;84(3):138-44. doi: 10.5414/CN108254.

PMID:
26226951
17.

Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.

Zand L, Nasr SH, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Kumar S, Kyle RA, Fervenza FC, Sethi S, Dingli D, Rajkumar SV, Kapoor P, McCurdy A, Leung N.

Leuk Lymphoma. 2015;56(12):3357-64. doi: 10.3109/10428194.2015.1040011. Epub 2015 May 12.

PMID:
25860232
18.

Pregnancy outcomes in autosomal dominant polycystic kidney disease: a case-control study.

Wu M, Wang D, Zand L, Harris PC, White WM, Garovic VD, Kermott CA.

J Matern Fetal Neonatal Med. 2016 Mar;29(5):807-12. doi: 10.3109/14767058.2015.1019458. Epub 2015 Mar 10.

19.

Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations.

Sethi S, Zand L, Nasr SH, Glassock RJ, Fervenza FC.

Clin Kidney J. 2014 Dec;7(6):531-7. doi: 10.1093/ckj/sfu100. Epub 2014 Sep 28.

20.

The Case | Renal dysfunction in a pregnant patient with IgA nephropathy.

Zand L, Williams A, Babovic-Vuksanovic D, Nwoko R, Cornell L, Garovic V.

Kidney Int. 2014 Jun;85(6):1477-8. doi: 10.1038/ki.2013.322. No abstract available.

21.

Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease.

Moua T, Zand L, Hartman RP, Hartman TE, Qin D, Peikert T, Qian Q.

PLoS One. 2014 Apr 18;9(4):e93674. doi: 10.1371/journal.pone.0093674. eCollection 2014.

22.

Does tonsillectomy have a role in the treatment of patients with immunoglobulin A nephropathy?

Zand L, Fervenza FC.

Nephrol Dial Transplant. 2014 Aug;29(8):1456-9. doi: 10.1093/ndt/gfu068. Epub 2014 Apr 10. Review. No abstract available.

PMID:
24723547
23.

Treatment of ANCA-associated vasculitis: new therapies and a look at old entities.

Zand L, Specks U, Sethi S, Fervenza FC.

Adv Chronic Kidney Dis. 2014 Mar;21(2):182-93. doi: 10.1053/j.ackd.2014.01.009. Review.

PMID:
24602467
24.

Membranoproliferative glomerulonephritis associated with autoimmune diseases.

Zand L, Fervenza FC, Nasr SH, Sethi S.

J Nephrol. 2014 Apr;27(2):165-71. doi: 10.1007/s40620-014-0049-0. Epub 2014 Feb 6.

PMID:
24500888
25.

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

Zand L, Lorenz EC, Cosio FG, Fervenza FC, Nasr SH, Gandhi MJ, Smith RJ, Sethi S.

J Am Soc Nephrol. 2014 May;25(5):1110-7. doi: 10.1681/ASN.2013070715. Epub 2013 Dec 19.

26.

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.

Franco Palacios CR, Lieske JC, Wadei HM, Rule AD, Fervenza FC, Voskoboev N, Garovic VD, Zand L, Stegall MD, Cosio FG, Amer H.

Transplantation. 2013 Aug 27;96(4):394-9. doi: 10.1097/TP.0b013e3182977ab1.

27.

C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA, Leung N, Cornell LD, Sethi S.

Am J Kidney Dis. 2013 Sep;62(3):506-14. doi: 10.1053/j.ajkd.2013.02.370. Epub 2013 Apr 26.

28.

Role of kidney Doppler ultrasonography in the diagnosis and management of anuric kidney failure.

Zand L, King BF, Qian Q.

Clin Nephrol. 2014 Aug;82(2):122-7. doi: 10.5414/CN107765.

PMID:
23253907
29.

Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.

Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ.

Kidney Int. 2013 Feb;83(2):293-9. doi: 10.1038/ki.2012.384. Epub 2012 Dec 12.

30.

Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation.

Zand L, Muriithi A, Nelsen E, Franco PM, Greene EL, Qian Q, El-Zoghby ZM.

Am J Med Sci. 2012 Dec;344(6):501-4. doi: 10.1097/MAJ.0b013e318259bd45.

PMID:
22986610
31.

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.

Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.

Kidney Int. 2012 Aug;82(4):465-73.

32.

Physical therapy-induced rhabdomyolysis and acute kidney injury associated with reduced activity of muscle lactate dehydrogenase A.

Lee BJ, Zand L, Manek NJ, Hsiao LL, Babovic-Vuksanovic D, Wylam ME, Qian Q.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1782-6. doi: 10.1002/acr.20584. No abstract available.

33.

Acute Kidney Injury in ADPKD Patients with Pneumonia.

Franco Palacios C, Keddis MT, Qin D, Zand L, Li G, Wang X, Cartin-Ceba R, Hartman RP, Qian Q.

Int J Nephrol. 2011;2011:617904. doi: 10.4061/2011/617904. Epub 2011 Jul 25.

34.

74-year-old woman with new-onset myoclonus.

Zand L, Hoffman SJ, Nyman MA.

Mayo Clin Proc. 2010 Oct;85(10):955-8. doi: 10.4065/mcp.2009.0572. No abstract available.

35.

Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity.

Zand L, McKian KP, Qian Q.

Am J Med. 2010 Apr;123(4):367-73. doi: 10.1016/j.amjmed.2009.09.030. Erratum in: Am J Med. 2011 Oct;124(10):e9.

PMID:
20362757
36.

Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

Sethi S, Zand L, Leung N, Smith RJ, Jevremonic D, Herrmann SS, Fervenza FC.

Clin J Am Soc Nephrol. 2010 May;5(5):770-82. doi: 10.2215/CJN.06760909. Epub 2010 Feb 25.

37.

Induction of angiogenesis in the beta-amyloid peptide-injected rat hippocampus.

Zand L, Ryu JK, McLarnon JG.

Neuroreport. 2005 Feb 8;16(2):129-32.

PMID:
15671861
38.

Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion.

Zand L, Qiang F, Roskelley CD, Leung PC, Auersperg N.

In Vitro Cell Dev Biol Anim. 2003 Mar-Apr;39(3-4):178-82.

PMID:
14505428
39.

A comparison of wedge and segmental resection of the lung.

Jacobson MJ, Zand L, Fox RT, Lees W.

Thorax. 1976 Aug;31(4):365-8.

40.

Scintigraphy of breast masses.

Raskin MM, Zand LC, Serafini AN.

Radiology. 1975 Feb;114(2):465-7.

PMID:
1111018
41.

Radionuclide breast scanning in carcinoma of the breast.

Serafini AN, Raskin MM, Zand LC, Watson DD.

J Nucl Med. 1974 Dec;15(12):1149-52. No abstract available.

Supplemental Content

Support Center